Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens

被引:133
作者
Iwasaki, Masashi [3 ]
Tanaka, Yoshimasa [1 ,2 ]
Kobayashi, Hirohito [4 ]
Murata-Hirai, Kaoru
Miyabe, Hideto
Sugie, Tomoharu [5 ]
Toi, Masakazu [5 ]
Minato, Nagahiro [1 ,3 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Lab Immunol & Cell Biol, Kyoto, Japan
[4] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan
关键词
gamma delta T cells; Phosphoantigen; PD-1; PD-L1; Tumor; NONPEPTIDE ANTIGENS; DILATED CARDIOMYOPATHY; MEDIATED RECOGNITION; ZOLEDRONIC ACID; TUMOR-CELLS; IN-VIVO; IMMUNOTHERAPY; RECEPTOR; B7-H1; PATHWAY;
D O I
10.1002/eji.201040959
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed cell death-1 (PD-1) is an inhibitory receptor and plays an important role in the regulation of alpha beta T cells. Little is known, however, about the role of PD-1 in gamma delta T cells. In this study, we investigated the expression and function of PD-1 in human gamma delta T cells. Expression of PD-1 was rapidly induced in primary gamma delta T cells following antigenic stimulation, and the PD-1(+) gamma delta T cells produced IL-2. When PD-1(+) gamma delta T cells were stimulated with Daudi cells with and without programmed cell death ligand-1 (PD-L1) expression, the levels of IFN-gamma production and cytotoxicity in response to PD-L1(+) Daudi cells were diminished compared to the levels seen in response to PD-L1(-) Daudi cells. The attenuated effector functions were reversed by anti-PD-L1 mAb. When PD-L1(+) gamma delta T cells were challenged by PD-L1(+) tumors pretreated with zoledronate (Zol), which induced gamma delta TCR-mediated signaling, the resulting reduction in cytokine production was only slight to moderate compared to the reduction seen when PD-L1(+) gamma delta T cells were challenged by PD-L1(-) tumors. In addition, cytotoxic activity of PD-L1(+) gamma delta T cells against Zol-treated PD-L1(+) tumors was comparable to that against Zol-treated PD-L1(-) tumors. These results suggest that TCR triggering may partially overcome the inhibitory effect of PD-1 in gamma delta T cells.
引用
收藏
页码:345 / 355
页数:11
相关论文
共 50 条
[11]   Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer [J].
Dieli, Francesco ;
Vermijlen, David ;
Fulfaro, Fabio ;
Caccamo, Nadia ;
Meraviglia, Serena ;
Cicero, Giuseppe ;
Roberts, Andrew ;
Buccheri, Simona ;
D'Asaro, Matilde ;
Gebbia, Nicola ;
Salerno, Alfredo ;
Eberl, Matthias ;
Hayday, Adrian C. .
CANCER RESEARCH, 2007, 67 (15) :7450-7457
[12]   B7-H1 pathway and its role in the evasion of tumor immunity [J].
Dong, HD ;
Chen, LP .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (05) :281-287
[13]  
Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
[14]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[15]   Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade [J].
Freeman, Gordon J. ;
Wherry, E. John ;
Ahmed, Rafi ;
Sharpe, Arlene H. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (10) :2223-2227
[16]  
Garcia VE, 1997, J IMMUNOL, V159, P1328
[17]   Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer [J].
Gnant, Michael ;
Mlineritsch, Brigitte ;
Schippinger, Walter ;
Luschin-Ebengreuth, Gero ;
Poestlberger, Sabine ;
Menzel, Christian ;
Jakesz, Raimund ;
Seifert, Michael ;
Hubalek, Michael ;
Bjelic-Radisic, Vesna ;
Samonigg, Hellmut ;
Tausch, Christoph ;
Eidtmann, Holger ;
Steger, Guenther ;
Kwasny, Werner ;
Dubsky, Peter ;
Fridrik, Michael ;
Fitzal, Florian ;
Stierer, Michael ;
Rucklinger, Ernst ;
Greil, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07) :679-691
[18]   Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells [J].
Gober, HJ ;
Kistowska, M ;
Angman, L ;
Jenö, P ;
Mori, L ;
De Libero, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :163-168
[19]  
Greenwald RJ., 2005, Annu Rev Immunol, V23, P515548
[20]   Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer [J].
Hamanishi, Junzo ;
Mandai, Masaki ;
Iwasaki, Masashi ;
Okazaki, Taku ;
Tanaka, Yoshimasa ;
Yamaguchi, Ken ;
Higuchi, Toshihiro ;
Yagi, Haruhiko ;
Takakura, Kenji ;
Minato, Nagahiro ;
Honjo, Tasuku ;
Fujii, Shingo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (09) :3360-3365